Randomised Controlled Trial of Pre-Procedure Virtual Bronchoscopy Planning Compared To Conventional Computed Tomographic Planning For Endobronchial Ultrasound Guide Sheath Procedures

Not Applicable

• Conditions: Peripheral pulmonary lesions; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12611000501943
• Lead Sponsor: Queensland Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-05-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Age 18-85
Patients with a peripheral pulmonary nodule undergoing EBUS GS directed biopsy for diagnosis

Exclusion Criteria

Pregnancy
Inability to provide consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Complication rate (pneumothorax, unplanned hospital admission, major and minor bleeding)[Upto one week after procedure];Diagnostic yield<br>Once the target lesion is localised using EBUS a minimum of 6 transbronchial biopsies, cytology brush samples and 5-10ml miniBAL will be taken for microbiology/culture/sensitivity, cytology and histology. Diagnostic yield will be calculated as :<br>number of procedures which provide a diagnosis / total number of procedures. <br><br>In cases where EBUS GS directed biopsies does not provide a diagnosis, the patient will be followed up for 12 months to determine whether other subsequent diagnostic modalities provide a histological diagnosis.[12 months after procedure];Procedure Time[Time of procedure]

Secondary Outcome Measures

Name	Time	Method
ocalisation of lesion on EBUS GS[At time of procedure]